CLINICAL_TRIALS
trial_result
· 2026-07-29
Clinical Trial Results: Botulinum Toxin in Raynaud's Phenomenon [Phase 4]
Summary
Phase 4 clinical trial results evaluating botulinum toxin for Raynaud's Phenomenon have been completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Emory University | Conditions: Raynaud Phenomenon | Phase 4 | Status: COMPLETED | Results posted: 2026-07-29